PHAT – phathom pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting [Yahoo! Finance]
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Form 10-Q Phathom Pharmaceuticals, For: Mar 31
Form 8-K Phathom Pharmaceuticals, For: May 09
Form DEFA14A Phathom Pharmaceuticals,
Form DEF 14A Phathom Pharmaceuticals, For: May 23
Form ARS Phathom Pharmaceuticals, For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.